Yves Lévy

6.1k total citations · 1 hit paper
104 papers, 4.0k citations indexed

About

Yves Lévy is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Yves Lévy has authored 104 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 49 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Yves Lévy's work include HIV Research and Treatment (48 papers), Immune Cell Function and Interaction (36 papers) and T-cell and B-cell Immunology (23 papers). Yves Lévy is often cited by papers focused on HIV Research and Treatment (48 papers), Immune Cell Function and Interaction (36 papers) and T-cell and B-cell Immunology (23 papers). Yves Lévy collaborates with scholars based in France, United States and Switzerland. Yves Lévy's co-authors include J C Brouet, Jean‐Daniel Lelièvre, Pierre Galanaud, Andréas Tsapis, D Alarcón-Segovia, B Morel-Fourrier, Weiguo Zou, D Émilie, John Wijdenes and Jorge Alcocer‐Varela and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Yves Lévy

100 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrating Genomics into Healthcare: A Global Responsibility

2019 242 citations Yves Lévy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yves Lévy France	35	2.1k	987	761	549	468	104	4.0k
Terri H. Finkel United States	34	2.6k 1.2×	1.5k 1.5×	1.0k 1.3×	576 1.0×	776 1.7×	88	4.6k
Nirmal K. Banda United States	33	2.5k 1.2×	1.2k 1.2×	1.3k 1.7×	512 0.9×	533 1.1×	87	4.7k
Yves Lévy France	35	2.3k 1.1×	1.5k 1.5×	726 1.0×	869 1.6×	926 2.0×	146	4.5k
Robert Balderas United States	35	3.9k 1.9×	987 1.0×	2.0k 2.6×	642 1.2×	452 1.0×	64	6.4k
Daniel Zagury France	35	2.4k 1.1×	2.0k 2.0×	885 1.2×	777 1.4×	740 1.6×	144	4.2k
Davide Gibellini Italy	36	1.2k 0.6×	1.6k 1.6×	1.3k 1.7×	864 1.6×	1.2k 2.5×	204	4.5k
Peter Ebbesen Denmark	35	1.1k 0.5×	594 0.6×	1.3k 1.6×	854 1.6×	790 1.7×	222	4.5k
Peter Erb Switzerland	35	1.8k 0.8×	579 0.6×	823 1.1×	971 1.8×	720 1.5×	128	4.3k
Peter D. Katsikis United States	46	4.1k 2.0×	1.2k 1.3×	1.9k 2.5×	1.1k 2.0×	572 1.2×	136	7.8k
Constantinos Petrovas United States	30	2.3k 1.1×	1.4k 1.4×	503 0.7×	788 1.4×	611 1.3×	85	3.4k

Countries citing papers authored by Yves Lévy

Since Specialization

Citations

This map shows the geographic impact of Yves Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Lévy more than expected).

Fields of papers citing papers by Yves Lévy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Lévy. The network helps show where Yves Lévy may publish in the future.

Co-authorship network of co-authors of Yves Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Lévy. A scholar is included among the top collaborators of Yves Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Lévy. Yves Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robineau, Olivier, Sophie Hüe, Mathieu Surénaud, et al.. (2025). Symptoms and pathophysiology of post-acute sequelae following COVID-19 (PASC): a cohort study. EBioMedicine. 117. 105792–105792. 1 indexed citations

Even, C., A. Aupérin, Christophe Le Tourneau, et al.. (2024). 157P Preliminary results of a multicentric randomized phase I/IIa trial of an immunotherapy targeting dendritic cells (DC), CD40HVac, in patients with HPV16-positive oropharyngeal carcinoma (OPC). Immuno-Oncology Technology. 24. 100786–100786.

Lévy, Yves. (2024). DNA and protein HIV vaccines: how should we mix it?. The Lancet HIV. 11(5). e274–e275.

Melica, Giovanna, Pablo Bartolucci, Étienne Audureau, et al.. (2023). Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial. Clinical Infectious Diseases. 76(11). 1949–1958. 2 indexed citations

Bendib, Inès, Asma Beldi‐Ferchiou, F. Schlemmer, et al.. (2021). Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS. Cells. 10(12). 3546–3546. 5 indexed citations

Tchérakian, Colas, Paul‐Louis Woerther, Aurélie Guguin, et al.. (2019). Overexpression of GILZ in macrophages limits systemic inflammation while increasing bacterial clearance in sepsis in mice. European Journal of Immunology. 50(4). 589–602. 24 indexed citations

Surénaud, Mathieu, et al.. (2016). Microbiome of HIV-infected people. Microbial Pathogenesis. 106. 85–93. 42 indexed citations

Sagoo, Pervinder, Zacarias Garcia, Béatrice Bréart, et al.. (2015). In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity. Nature Medicine. 22(1). 64–71. 103 indexed citations

Richert, Laura, et al.. (2015). Recent developments in clinical trial designs for HIV vaccine research. Human Vaccines & Immunotherapeutics. 11(4). 1022–1029. 7 indexed citations

10.

Desaint, Corinne, Christine Durier, Jean‐Daniel Lelièvre, et al.. (2014). Update of the Long-term Follow-up of Healthy Volunteers from Preventive HIV-1 Vaccine Trials: ANRS COV1-COHVAC Cohort. AIDS Research and Human Retroviruses. 30(S1). A189–A190. 1 indexed citations

11.

Arnold, Vincent, et al.. (2014). Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVA HIV. Vaccine. 32(43). 5577–5584. 7 indexed citations

12.

Weiss, Laurence, Matthieu Carrière, Brice Targat, et al.. (2010). In vivo expansion of naive and activated CD4 ⁺ CD25 ⁺ FOXP3 ⁺ regulatory T cell populations in interleukin-2–treated HIV patients. Proceedings of the National Academy of Sciences. 107(23). 10632–10637. 69 indexed citations

13.

Campillo-Gimenez, L., Marie‐Christine Cumont, Michèle Fay, et al.. (2009). AIDS Progression Is Associated with the Emergence of IL-17–Producing Cells Early After Simian Immunodeficiency Virus Infection. The Journal of Immunology. 184(2). 984–992. 48 indexed citations

14.

Viard, Jean‐Paul, Catherine Fagard, Marie‐Laure Chaix, et al.. (2009). Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients. AIDS. 23(11). 1383–1388. 9 indexed citations

15.

Melica, Giovanna, Pierre Brugières, Anne‐Sophie Lascaux, Yves Lévy, & Jean‐Daniel Lelièvre. (2009). Primary vasculitis of the central nervous system in patients infected with HIV‐1 in the HAART era. Journal of Medical Virology. 81(4). 578–581. 20 indexed citations

16.

Dorival, Céline, Jean‐Daniel Lelièvre, Nathalie Sol‐Foulon, et al.. (2008). HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursor. Virology. 377(1). 207–215. 10 indexed citations

17.

Durier, Christine, Odile Launay, Vincent Meiffrédy, et al.. (2006). Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults. AIDS. 20(7). 1039–1049. 49 indexed citations

18.

Oksenhendler, Éric, Laurence Gérard, Yves Lévy, et al.. (2000). Intensive Chemotherapy (LNHIV-91 Regimen) and G-CSF for HIV Associated Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 39(1-2). 87–95. 14 indexed citations

19.

Lascaux, Anne‐Sophie, Delphine Bonhomme, & Yves Lévy. (1999). Déficit immunitaire commun variable. 5(4). 291–297. 2 indexed citations

20.

Llorente, Luis, Weiguo Zou, Yves Lévy, et al.. (1995). Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.. The Journal of Experimental Medicine. 181(3). 839–844. 440 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact